Plan: OPEN | Option: Dividend | Sailesh Raj Bhan

22 Feb 19 | 12:00 AM

55.89 0.14 (0.25%)

  • Outperforms

    7.37%

    Return (1Y)

    beaten by 9.48%

  • Less Volatile

    0.96%

    Standard Deviation (1Y)

    Lower than by -0.37%

  • Consistent

    8/12

    Months

    Has beaten

  • Value research rating

    Not Rated

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Reliance Pharma Fund (D), has beaten its benchmark, by 9.48% (CAGR difference)

7.37%

Outperforms

This is +ve Alpha

Performance Chart for Rs

Invested in

Risk

In last 1 year , the volatility of Reliance Pharma Fund (D),is Lower than its benchmark, by -0.37%

0.96%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 8 out of Last 12 Months, i.e 66.67% of the times It has beaten its benchmark,

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, 6 Stocks beating the benchmark 13 Stocks not beating the benchmark

View Stock Composition